Infectious Disease Connect

What Infectious Disease Connect does

Infectious Disease Connect (ID Connect) is a U.S.-based telemedicine company founded in 2019 and headquartered in Pittsburgh, PA, that delivers infectious-disease clinical services, antimicrobial stewardship, and infection-prevention support to hospitals and health systems on a subscription basis. The company sells direct to enterprise healthcare buyers through a field sales motion, targeting acute-care hospitals (with a particular focus on rural and community facilities lacking on-site ID physician coverage), multi-hospital health systems, and children's hospitals/NICUs. Its core service portfolio comprises ID Telemedicine (Tele-ID) for real-time physician consultations with live nurse tele-presenter support, Tele-Antimicrobial Stewardship (Tele-ASP) for prospective audit and feedback, Tele-Infection Prevention and Control (Tele-IPC), and Tele-OPAT for post-discharge IV antibiotic monitoring. Specialty extensions include Pediatric Tele-ID and a multi-facility Health System Solutions coverage model.

The technology stack pairs clinical services with the ILÚM software platform — ILÚM Insight and ILÚM Inform — acquired via the 2020 purchase of ILÚM Health Solutions. ILÚM Insight is an ONC-certified Health IT Module (cert #15.05.05.3174.IDCT.01.00.0.231106, certified Nov 6, 2023) providing clinical decision support and NHSN AUR Module reporting, with SAML/LDAP integration, multi-factor authentication, end-to-end encryption, and structured JSON Electronic Health Information export. The ILÚM products automate antimicrobial stewardship workflows, deliver real-time evidence-based therapy guidance, and enable hospitals to meet CDC/CMS antimicrobial-use and resistance reporting requirements. Clinical staff are exclusively academic ID physicians and pharmacists affiliated with UPMC/University of Pittsburgh, including pediatric and transplant-ID specialists.

ID Connect generates revenue through recurring subscription and service contracts with hospitals and health systems, with pricing determined per engagement scope and not publicly disclosed. The company has institutional backing from UPMC Enterprises (strategic investor, announced Jan 2026), FT Capital Partners, and the Merck Global Health Innovation Fund, and operates with 11–50 employees. Documented customer outcomes include up to 60% reductions in patient transfer rates to tertiary centers, 20% reductions in average length of stay, $1.25M in annualized cost savings per health system, 41% reductions in hospital-onset C. difficile infections, and 277–318% ROI at partner hospitals such as Armstrong County Memorial Hospital.

Name

Infectious Disease Connect

Legal name

Infectious Disease Connect, Inc.

Website

https://idctelemed.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Infectious Disease Connect is a U.S. telemedicine company providing academic infectious-disease physician consultations, antimicrobial stewardship, and infection-prevention services to hospitals and health systems on subscription contracts, with a particular focus on rural and community facilities lacking on-site ID coverage.

Ownership category

akta.pro rank

Product category

Infectious Disease Telemedicine Services

NAICS

Other Ambulatory Health Care Services (6219), Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Infectious Disease Telemedicine Platforms (HLALAGAJ)

akta.pro secondary industry

Virtual Specialty Care Platforms (tele-stroke, tele-ICU, tele-derm, tele-cardiology) (HLALABAD)

Keywords

• Infectious disease telemedicine
• Antimicrobial stewardship services
• Tele-infection prevention
• Clinical decision support software
• Hospital specialty consultations

Headquarters

HQ city

Pittsburgh

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. ID Telemedicine Services: ID Connect provides telemedicine-based ID physician services to hospitals and health systems. Academic ID physicians deliver real-time consultations, antimicrobial stewardship, and infection prevention support remotely. Services are customized to each facility's needs and are priced as a subscription or service contract.
2. Clinical Decision Support Software (ILÚM Insight): The ILÚM Insight software is offered as a subscription/licensing product to hospitals requiring antimicrobial stewardship decision support and NHSN AUR reporting. Additional subscription costs apply for NHSN AUR reporting features. Revenue is generated through software licensing and support contracts.
3. Virtual Antimicrobial Stewardship (Tele-ASP): Virtual ASP services provided to hospitals and health systems, including prospective audit and feedback, guideline development, staff education, and regulatory compliance support. Delivered by ID physicians and pharmacists via a tele-ASP model billed as a recurring service.
4. Tele-Infection Prevention & Control: Remote infection prevention and control services including policy review, outbreak management, and best-practice implementation support. Delivered as a subscription or service engagement.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Infectious Disease Connect delivers telemedicine-based infectious disease clinical services to hospitals and health systems, including remote ID physician consultations, virtual antimicrobial stewardship (Tele-ASP), tele-infection prevention and control (Tele-IPC), and Tele-OPAT post-discharge monitoring. The company supplements these services with ILÚM Insight and ILÚM Inform, ONC-certified clinical decision support software for antimicrobial stewardship and NHSN AUR Module reporting. All services are staffed by academic ID physicians and delivered remotely via a proprietary telemedicine platform.

Product overview

Infectious Disease Connect is a telemedicine platform offering a portfolio of infectious disease care solutions. The core offerings include ID Telemedicine (Tele-ID), Tele-Antimicrobial Stewardship (Tele-ASP), Tele-Infection Prevention Control (Tele-IPC), and Tele-OPAT services. The company also acquired ILÚM Health Solutions to provide ILÚM Insight and ILÚM Inform clinical decision support software products. Specialized solutions include Pediatric Telemedicine for children's hospitals and Health System Solutions for multi-facility networks. The platform delivers academic-level ID expertise remotely to hospitals and health systems.

Differentiator

Problem solved

Functional benefit

Brands

• ILÚM Insight: Clinical decision support software for antimicrobial stewardship with NHSN AUR Module reporting capabilities. Certified under ONC Health IT Certification Criteria.
• ILÚM Inform

Products and services

• ID Telemedicine (Tele-ID)

Quantifiable outcome

• Transfer rates to tertiary centers reduced by up to 60%
• +8 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• University of New Mexico Sandoval Regional Medical Center (UNM SRMC)coreStrategic or Co-development PartnerID Connect and UNM SRMC co-authored and released a groundbreaking white paper titled 'Reducing Infectious Diseases (ID) Patient Average Length of Stay Through ID Telemedicine in Short Term Acute Care Hospitals.' The partnership demonstrated a 20% reduction in average length of stay for ID patients through the integration of ID Connect's telemedicine and tele-OPAT programs. This represents a co-research and co-publishing strategic partnership.
• ILÚM Health SolutionscoreTechnology or IntegrationID Connect acquired ILÚM Health Solutions in 2020, bringing proprietary real-time clinical decision support software (ILÚM Insight and ILÚM Inform) into the ID Connect portfolio. The co-founder and former COO of ILÚM Health Solutions (Riaan Erwee) now serves as Chief Operating Officer of ID Connect.

Scale indicators8 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• BD (Becton Dickinson): BD is a global medical technology leader with major infection prevention and antimicrobial stewardship offerings (e.g., BD Insights, Pyxis), competing as a broader incumbent in the ASP/IPC software and services market ID Connect addresses.
• Sound Physicians: Sound Physicians is a large, established acute-care services partner for hospitals offering hospital medicine, critical care, emergency medicine, and tele-specialty services, providing broader competition in enterprise hospital service contracts.
• Premier Inc. Premier is a large healthcare performance improvement company serving U.S. hospitals with data, consulting, and infection-related services, competing indirectly with ID Connect's Tele-IPC and ASP offerings through enterprise hospital relationships.

Direct peers

• Equum Medical: Equum Medical delivers acute care tele-specialty services to hospitals including tele-infectious disease, antimicrobial stewardship, and remote nursing support, overlapping closely with ID Connect's core offerings.
• Eagle Telemedicine: Eagle Telemedicine provides specialty tele-consultation services to hospitals, including infectious disease coverage, and is one of the closest direct competitors to ID Connect in tele-ID delivery model and customer base.
• Access TeleCare: Access TeleCare (formerly SOC Telemed) is a leading specialty telemedicine provider for hospitals and health systems, offering tele-infectious disease among other specialties, directly competing with ID Connect for hospital ID coverage contracts.

Emerging players

• AristaMD: AristaMD provides specialist eConsult and referral management for hospitals and health systems, partially overlapping with ID Connect's specialty consult and ASP workflows as a digital specialty care platform.

Others

• Wolters Kluwer (Sentri7): Wolters Kluwer's Sentri7 is a leading clinical surveillance and antimicrobial stewardship software platform used by hospitals, overlapping with ID Connect's ILÚM Insight as a competing ASP/CDS technology layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/idconnect1
• LinkedInlinkedin.com/company/infectious-disease-connect

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Infectious Disease Connect